ALIVUS LIFE SCIENCES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Alivus Life Sciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.29₹ 2.65
As on Oct 30, 2025, 4:01 PM IST
Alivus Life Sciences Price Performance
Today's LowToday's High
₹904.50₹915.65
₹910.00
52 Weeks' Low52 Weeks' High
₹827.10₹1,259.75
₹910.00
Open Price
₹907.65
Prev. Close
₹907.35
Volume
28,500
Over the last 5 years, the share price of Alivus Life Sciences has gained 3.99% CAGR. Over the past year, the corresponding return has been -11.31%.
Alivus Life Sciences’s current P/E of 22.52x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Low Price Blue Chips stocks Screener.
Alivus Life Sciences Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Alivus Life Sciences | -1.52 | -3.08 | -11.68 | -16.43 | -13.56 | 28.85 | 3.99 |
| Sun Pharmaceutical Industries | 0.24 | 4.12 | -0.11 | -6.84 | -7.87 | 18.80 | 29.61 |
| Divi's Laboratories | 0.89 | 16.39 | 0.70 | 8.95 | 12.77 | 22.60 | 16.18 |
| Cipla | -2.73 | 1.76 | -0.88 | 0.97 | -0.82 | 9.72 | 15.36 |
| Torrent Pharmaceuticals | 0.55 | 0.98 | -3.84 | 10.50 | 12.37 | 29.69 | 22.92 |
| Mankind Pharma | 0.58 | 0.29 | -4.75 | 2.68 | -8.28 | 19.76 | 11.42 |
| Dr. Reddy's Laboratories | -6.37 | -3.54 | -5.41 | 1.63 | -5.66 | 10.70 | 4.22 |
| Zydus Lifesciences | -1.94 | -0.57 | 1.66 | 11.37 | -1.57 | 31.49 | 18.74 |
| Lupin | 0.57 | -1.98 | 0.71 | -5.60 | -11.15 | 40.64 | 16.42 |
| Alkem Laboratories | -0.43 | 1.14 | 9.75 | 8.86 | -4.52 | 20.51 | 15.96 |
| Aurobindo Pharma | 1.46 | 1.28 | -3.50 | -9.17 | -21.13 | 26.93 | 7.34 |
| Abbott India | -1.07 | -0.83 | -13.94 | -3.67 | 2.24 | 15.44 | 14.12 |
| Glenmark Pharmaceuticals | 3.55 | -3.86 | -11.72 | 36.89 | 11.21 | 66.99 | 31.70 |
| Laurus Labs | 4.84 | 11.23 | 10.95 | 56.36 | 97.19 | 28.74 | 24.89 |
| Biocon | 4.97 | 8.80 | -3.61 | 18.31 | 19.25 | 11.87 | -1.35 |
| GlaxoSmithKline Pharmaceuticals | -4.99 | -3.03 | -17.26 | -8.39 | -3.93 | 23.79 | 12.26 |
| Anthem Biosciences | -0.35 | -7.04 | -5.45 | -1.78 | -1.78 | -0.60 | -0.36 |
| Ipca Laboratories | 1.61 | -2.97 | -12.56 | -6.54 | -18.86 | 12.52 | 2.18 |
| Gland Pharma | -1.40 | -3.44 | -7.41 | 36.14 | 15.84 | 2.33 | 0.99 |
| Ajanta Pharma | 1.97 | 2.59 | -10.54 | -4.78 | -19.89 | 23.76 | 18.58 |
Over the last one year, Alivus Life Sciences has declined 13.56% compared to peers like Sun Pharmaceutical Industries (-7.87%), Divi's Laboratories (12.77%), Cipla (-0.82%). From a 5 year perspective, Alivus Life Sciences has underperformed peers relative to Sun Pharmaceutical Industries (29.61%) and Divi's Laboratories (16.18%).
Alivus Life Sciences Financials
Alivus Life Sciences Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 919.38 | 912.62 |
| 10 | 923 | 917.71 |
| 20 | 928.73 | 925.53 |
| 50 | 943.29 | 944.16 |
| 100 | 977.01 | 970.16 |
| 200 | 1,023.77 | 989.43 |
Alivus Life Sciences Share Holding Pattern
In the latest quarter, Alivus Life Sciences saw a drop in promoter holding to 74.91%, while DII stake decreased to 5.47%, FII holding rose to 6.84%, and public shareholding moved down to 12.79% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Alivus Life Sciences Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 12,48,114 | 0.4 | 115.97 | |
| 10,88,244 | 1.49 | 101.11 | |
| 10,992 | 0.83 | 1.02 |
* Excluding Index & Arbitrage Funds
Alivus Life Sciences Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 30, 2025, 9:16 PM IST | Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 29, 2025, 11:06 PM IST | Alivus Life Sciences - Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter And Half Year |
| Oct 20, 2025, 3:16 PM IST | Alivus Life Sciences - Disclosure under Regulation 30 of LODR |
| Oct 02, 2025, 5:16 PM IST | Alivus Life Sciences - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And |
| Sep 16, 2025, 9:08 PM IST | Alivus Life Sciences - Announcement under Regulation 30 (LODR)-Credit Rating |
About Alivus Life Sciences
Alivus Life Sciences Ltd. is a Public Limited Listed company incorporated on 23/06/2011 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L74900PN2011PLC139963 and registration number is 139963. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 2386.88 Cr. and Equity Capital is Rs. 24.51 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No. 170-172, Solapur Maharashtra 413213
- Contact
Management
- Mr. Hiren K PatelChairman & Non-Exe.Director
- Dr. Yasir RawjeeManaging Director & CEO
- Mr. Vinod NaikExecutive Director
- Mr. Kaushikbhai N PatelIndependent Director
- Dr. Savan GodiawalaIndependent Director
- Mr. Taruvai Laxminarayanan EaswarIndependent Director
- Mrs. Manju AgarwalIndependent Director
FAQs on Alivus Life Sciences Share Price
What is the share price of Alivus Life Sciences?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Alivus Life Sciences is ₹910.00 as on Oct 30, 2025.
What kind of stock is Alivus Life Sciences?
The Alivus Life Sciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Alivus Life Sciences?
The market cap of Alivus Life Sciences is ₹11,164.00 Cr as on Oct 30, 2025.
What are today's High and Low prices of Alivus Life Sciences?
Today’s highest and lowest price of Alivus Life Sciences are ₹915.65 and ₹904.50.
What are the 52 Week High and 52 Week Low of Alivus Life Sciences?
The 52-week high/low is the highest and lowest price at which Alivus Life Sciences stock has traded in the past 52-week or nearly a year. The 52-week high of Alivus Life Sciences is ₹1,259.75 and 52-week low of Alivus Life Sciences is ₹827.10 as on Oct 30, 2025.
How has the Alivus Life Sciences performed historically in terms of returns?
The Alivus Life Sciences has shown returns of 0.29% over the past day, -2.08% for the past month, -13.33% over 3 months, -11.31% over 1 year, 28.85% across 3 years, and 3.99% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Alivus Life Sciences?
P/E ratio of and PB ratio of Alivus Life Sciences are 22.52 and 3.96 on Oct 30, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse